Home/Filings/4/0000899243-21-021777
4//SEC Filing

McGrath Yvonne 4

Accession 0000899243-21-021777

CIK 0001808865other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:17 PM ET

Size

14.8 KB

Accession

0000899243-21-021777

Insider Transaction Report

Form 4
Period: 2021-06-01
McGrath Yvonne
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-06-02$4.23/sh+323$1,366323 total
  • Sale

    Common Stock

    2021-06-02$20.00/sh323$6,4600 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-06-017,604103,373 total
    Exercise: $4.23Exp: 2030-05-01Common Stock (7,604 underlying)
  • Exercise/Conversion

    Common Stock

    2021-06-01$4.23/sh+7,604$32,1657,604 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-06-02323103,050 total
    Exercise: $4.23Exp: 2030-05-01Common Stock (323 underlying)
  • Sale

    Common Stock

    2021-06-01$20.18/sh7,604$153,4430 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.95, inclusive. The reporting person undertakes to provide to iTeos Therapeutics, Inc., any security holder of iTeos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through such date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through each applicable vesting date.

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1
  • filerCIK 0001816213

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:17 PM ET
Size
14.8 KB